AstraZeneca and Oracle team up on AI to find patients for drug trials

AstraZeneca and Oracle will use AI and real patient health data to find people for drug trials faster, the two firms announced. The deal adds to a long list of AI health tie-ups between drugmakers and tech companies. The pair signed a non-binding term sheet, so the terms are not yet final, and neither firm said or […] This story continues at The Next Web